Abstract: A display device includes a substrate, a first transistor including a first active layer disposed on the substrate and a first gate electrode disposed on the first active layer, and a first gate insulating layer disposed between the first active layer and the first gate electrode. The first active layer includes an oxide semiconductor containing indium (In) at a content range of about 40 at % to about 54 at %, and the first gate insulating layer has an emission amount range of oxygen (O2) of about 2.48E+19 Molec./cm3 to about 2.76E+19 Molec./cm3, or an emission amount range of nitrogen monoxide (NO) of about 1.04E+20 Molec./cm3 to about 1.15E+20 Molec./cm3 under heat treatment conditions performed at a temperature range of about 50° C. to about 550° C.

Abstract: Provided are a resist topcoat composition and a method of forming patterns using the resist topcoat composition, the resist topcoat composition including a copolymer including a first structural unit represented by Chemical Formula M-1, a second structural unit represented by Chemical Formula M-2; at least one acidic compound selected from a sulfonic acid compound containing at least one fluorine, a sulfonimide compound containing at least one fluorine, and a carboxylic acid compound containing at least one fluorine; and a solvent.

Abstract: Provided are a resist topcoat composition and a method of forming patterns using the resist topcoat composition, the resist topcoat composition including a copolymer including a first structural unit represented by Chemical Formula M-1, a second structural unit represented by Chemical Formula M-2, and a third structural unit represented by Chemical Formula M-3A or Chemical Formula M-3B; and a solvent.

Abstract: The present application relates to a rotational joint and a device having the same. The rotational joint includes a joint housing, a driving device mounted in the joint housing, and an encoder module mounted on the driving device. The driving device includes inner shaft and an outer shaft surrounding the inner shaft and radially spaced apart from the inner shaft. The encoder module includes a first disk assembly configured to rotate synchronously with the outer shaft, a second disk assembly configured to rotate synchronously with the inner shaft, a first sensor assembly disposed adjacent to the first disk assembly to detect movement of a disk of the first disk assembly, and a second sensor assembly disposed adjacent to the second disk assembly to detect movement of a disk of the second disk assembly. A disk surface of the first disk assembly and a disk surface of the second disk assembly are arranged to be coplanar and radially spaced apart by at least a predetermined distance.

Abstract: An optical communication method and system with high spectral efficiency and low power consumption based on joint channel coding modulation relates to the technical field of high-speed fiber communication. The method includes a data acquisition step, a symbol multiplexing joint channel coding modulation step, a signal optical communication step, a channel equalization step, and a symbol demultiplexing step. The optical communication method and system improves the problems of relative independence of forward error correction channel coding (FEC) and high order modulation function modules, long code length dependence of FEC, limited spectral efficiency promotion under the limitation of fiber nonlinear effect, and high FEC decoding latency and power consumption in optical communication system. It is beneficial to improving the spectral efficiency and capacity of a coherent optical communication system and optimizing the system latency and power consumption.

Abstract: Disclosed are compositions comprising a composition comprising beta-glucan, yeast cell wall, direct fed microbials (Yeast+DFM), and L-carnitine and methods of using the compositions for improving the nutritional status, improving growth performance and survivability in an animal by administering the composition to the animal. Importantly, administering the Yeast+DFM in combination with L-carnitine results in a synergistic restoration of the insufficient level of circulating vitamin A in the animal.

Abstract: A method of preparing a core-shell structured quantum dot particle includes the steps of (a) preparing a core of quantum dot particle containing indium (In) and phosphorus (P) and (b) forming a shell by reacting the core of the quantum dot particles prepared in step (a), a zinc oxo cluster represented by Formula 1 below, and at least one anion precursor containing a group 16 element.

Abstract: Provided are a compound of Formula 37 capable of improving luminous efficiency, stability and lifetime of an organic electronic element employing the same, an organic electronic element using the same, and an electronic device thereof.

Abstract: This application discloses example data management methods. One example method includes obtaining, by a first terminal device, metadata of a target file in response to an access operation performed by a user on the target file through a first application, where the target file is stored in a local storage device, the first application is different from a second application, the second application is a dedicated application that is of the local storage device and that is installed on the first terminal device, and the first terminal device stores the metadata of the target file. The first terminal device sends an access request to the local storage device, where the access request includes the metadata of the target file. The first terminal device receives the target file sent by the local storage device.

Abstract: A backlight module and a display apparatus. The backlight module includes: a back panel, including a base plate and a vertical plate connected with an edge of the base plate; the base plate is matched with the vertical plate to form an accommodation space; a light guide plate, located in the accommodation space and having a safety gap with the vertical plate of the back panel; and an optical film, located in the accommodation space and located on a side of the light guide plate away from the base plate. A surface of the light guide plate facing the optical film has a first positioning portion and a second positioning portion; the first positioning portion positions the optical film in a first direction, and the second positioning portion positions the optical film in a second direction. The first direction and the second direction are perpendicular to each other.

Abstract: A soot-suppression flame-separation combustion device for combustion calorimetry and in-situ free radicals monitoring is mainly composed of a premixed combustion gas guide tube, an inner flame generating seat, an oxidation flame separation guide, and a sample combustion chamber. The inner flame generating seat is arranged in the premixed combustion gas guide tube, the oxidation flame separation guide is arranged on the premixed combustion gas guide outlet end of the premixed combustion gas guide tube, the sample combustion chamber is a cavity arranged inside the oxidation flame separation guide, and the oxidation flame separation guide is evenly arranged with at least 4 oxidation flame separation guide paths in a manner of surrounding the sample combustion chamber. The combustion device utilizes the special structure of the oxidation flame separation guide to suppress the generation of smoke and limit the smoke particles to a specific combustion area.

Abstract: A drug eluting balloon loaded with a drug in bulk, without any extra coating to host the said drug, and the method of preparing a drug eluting balloon which directly loads the drug on the balloon without coating, by using supercritical carbon dioxide to dissolve the drug and impregnate the balloons. The carbon dioxide is then released by pressure reduction, leaving only the drug on the balloon. Under suitable processing conditions, this method can form the drug uniformly on the surface of the balloon while maintaining the exterior morphology of the balloon, with a minimal increase in balloon thickness, and achieve satisfactory drug loading.

Abstract: A method and a system for rhythmic motion control of a robot based on a neural oscillator, including: acquiring a current state of the robot, and a phase and a frequency generated by the neural oscillator; and obtaining a control instruction according to the acquired current state, phase and frequency and a preset reinforcement learning network so as to control the robot. The preset reinforcement learning network includes an action space, a pattern formation network and the neural oscillator. A control structure designed by the present disclosure, which is composed of the neural oscillator and the pattern formation network, can ensure formation of an expected rhythmic motion behavior; and meanwhile, a designed action space for joint position increment can effectively accelerate the training process of rhythmic motion reinforcement learning, and solve a problem that design of the reward function is time-consuming and difficult in learning with existing model-free reinforcement learning.

Abstract: The present invention provides methods of improve efficiency, growth, and performance in an animal by orally administering to the animal an effective amount of a therapeutic clay. The methods can reduce embryonic loss, increase litter size, increase the number of live births, improve the immune status of the maternal animal, reduce the concentration of maternal fecal amino acids, reduce the concentration of maternal fecal short-chained amino acid, increasing litter birth weight in the maternal animal, increase the amount of young animal colostrum intake, reduce young animal pre-weaning mortality, reduce the number of young animals lost due to low viability, reduce the number of weaned young animals, improve the immune status of young animals at weaning, reduce the number of lightweight young animals from nursery to market, increase the number of young animals marketed per sow, and increase calculated litter weight gain.

Abstract: The present disclosure provides feed composition comprising at least one cyclopropenoid fatty acids or at least one conjugated linoleic acid and at least one cyclopropenoid fatty acids with normal or basal feed. After administration of one of the feed compositions, improved health aspects, reduced health issues, reduced mortality, increased carcass gain and repartitioning nutrients to muscles, and controlled carcass iodine value in non-human animals as compared to a control group not fed with the feed composition.

Abstract: The present invention provides antimicrobial feed supplement compositions comprising clay, and methods of treating microbial infections in an animal using the antimicrobial compositions.

Abstract: The present invention provides methods of improve efficiency, growth, and performance in an animal by orally administering to the animal an effective amount of a therapeutic clay. The methods can reduce embryonic loss, increase litter size, increase the number of live births, improve the immune status of the maternal animal, reduce the concentration of maternal fecal amino acids, reduce the concentration of maternal fecal short-chained amino acid, increasing litter birth weight in the maternal animal, increase the amount of young animal colostrum intake, reduce young animal pre-weaning mortality, reduce the number of young animals lost due to low viability, reduce the number of weaned young animals, improve the immune status of young animals at weaning, reduce the number of lightweight young animals from nursery to market, increase the number of young animals marketed per sow, and increase calculated litter weight gain.

Abstract: The present disclosure provides feed composition comprising at least one cyclopropenoid fatty acids or at least one conjugated linoleic acid and at least one cyclopropenoid fatty acids with normal or basal feed. After administration of one of the feed compositions, improved health aspects, reduced health issues, reduced mortality, increased carcass gain and repartitioning nutrients to muscles, and controlled carcass iodine value in non-human animals as compared to a control group not fed with the feed composition.

Abstract: The present invention provides methods of improve efficiency, growth, and performance in an animal by orally administering to the animal an effective amount of a therapeutic clay. The methods can reduce embryonic loss, increase litter size, increase the number of live births, improve the immune status of the maternal animal, reduce the concentration of maternal fecal amino acids, reduce the concentration of maternal fecal short-chained amino acid, increasing litter birth weight in the maternal animal, increase the amount of young animal colostrum intake, reduce young animal pre-weaning mortality, reduce the number of young animals lost due to low viability, reduce the number of weaned young animals, improve the immune status of young animals at weaning, reduce the number of lightweight young animals from nursery to market, increase the number of young animals marketed per sow, and increase calculated litter weight gain.

Abstract: The present disclosure provides feed composition comprising at least one cyclopropenoid fatty acids or at least one conjugated linoleic acid and at least one cyclopropenoid fatty acids with normal or basal feed. After administration of one of the feed compositions, improved health aspects, reduced health issues, reduced mortality, increased carcass gain and repartitioning nutrients to muscles, and controlled carcass iodine value in non-human animals as compared to a control group not fed with the feed composition.